Wellbeing Digital Sciences Inc.

09/01/2023

A Hawaii psychedelics task force that was recently established under the governor’s office has held its first meeting as experts work to prepare the state to potentially allow regulated access to novel therapies like psilocybin and M**A.

A Hawaii psychedelics task force that was recently established under the governor’s office has held its first meeting as experts work to prepare the state to potentially allow regulated access to novel therapies like psilocybin and M**A. The Office of Wellness and Resilience said that the Breakthr...

08/31/2023

Big news in the space. Otsuka Pharmaceutical has acquired Mindset Pharma, a microcap psychedelic stock developing medications to treat neuropsychiatric and neurological disorders with unmet medical needs. Big Pharma is taking notice.

Otsuka Pharmaceutical has acquired Mindset Pharma, a microcap psychedelic stock developing drugs for psychiatric and neurological disorders.

08/24/2023

Did you know? 1 in 4 people globally are affected by mental health challenges. Wellbeing Digital's subsidiary KGK is focused on groundbreaking research that drives us closer to more effective treatments. We're shaping the future of mental health care. Stay tuned for more! 💡

08/18/2023

A bill that would decriminalize certain natural, hallucinogenic drugs like psilocybin is making its way through the legislature. Authored by Sen. Scott Wiener (D-San Francisco), Senate Bill 58 (SB 58) would decriminalize the personal possession and use of five psychedelic substances - psilocybin, psilocin DMT, mescaline and ibogaine – for adults 21 and older in California.

08/17/2023

In recent years, psychedelic drugs have become a focal point of legislative reform in the United States. With states grappling to find the right balance between accessibility, regulation, and medical application, a patchwork of state-level reforms has emerged, sparking important discussions among healthcare professionals, policymakers, and the public.

Psychedelics Reform: A Shift in Legislative Landscape - Express Healthcare Management

08/11/2023

American companies are embracing psychedelic therapy as a unique workplace benefit for employees seeking alternative treatments for mental health conditions.

08/10/2023

The bill aims to create a grant program within the Department of Defense to conduct research into the use of psychedelics to treat post traumatic stress disorder and traumatic brain injuries in active-duty service members. It has rare, bipartisan support with cosponsors on both sides of the aisle.

“If I hadn’t gone through it, my son would have a folded flag, and instead, he has a father,” Lubecky said.

08/08/2023

The most optimistic scientists say we already have plenty of evidence to show that psychedelics can be incredibly powerful tools that could revolutionize mental health care in the U.S. They argue that we’re only at the beginning of understanding how transformative psychedelic therapy could be once the rigid restrictions that limit its availability are lifted.

Trials pairing drugs like M**A and magic mushrooms with traditional therapy have shown remarkable benefits for people struggling with depression, PTSD, addiction and other conditions.

08/07/2023

Mark Messier revealed how a psychedelic mushrooms experience in Barbados molded his legendary NHL career.

Mark Messier's six Stanley Cup wins are celebrated by hockey fans worldwide, but little is known about the transformative experience that shaped his path to greatness.

08/04/2023

Psychedelic-based therapy shows great promise in treating disorders ranging from depression and anxiety, to chronic pain and PTSD. One of the populations that could benefit greatly from these treatments is U.S. veterans.

River to River, host Ben Kieffer speaks with a Marine Corps veteran who now advocates for psychedelic-based therapy. Check out the episode to find out more about the benefits of psychedelic treatment.

Psychedelic drugs like psilocybin and M**A have become a very active area of medical research.

08/03/2023

Questions, confusion and concerns abound as the Oregon Health Authority finalizes the regulatory framework to manufacture psilocybin, or psychedelic mushrooms, and administer it to treat anxiety, depression, PTSD and addiction.

So far, six licensed psilocybin service centers have received a license. It's up to them when they want to open their doors to clients.

07/28/2023

Calling all mental health champions! Stay informed and be part of the mental health revolution. Sign up for our newsletter to receive timely updates on groundbreaking research, innovative solutions, and industry news. Don't miss out on exclusive insights from top experts in the field!
wellbeingdigital.co

$MEDI $KONEF